OpGen Receives FDA Clearance for AcuitasĀ® AMR Gene Panel
Go back to OpGen Receives FDA Clearance for AcuitasĀ® AMR Gene Panel(NASDAQ: OPGN) | Delayed: 0.49 +0.01 (2.08%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.48 | 52 Week High | $4.65 | |||
Open | $0.50 | 52 Week Low | $0.87 | |||
Day High | $0.50 | P/E | N/A | |||
Day Low | $0.45 | EPS | $0.00 | |||
Volume | 162,748 |